Several lines of experimental evidence support the notion that endoglin potentiates ALK1 signaling, including the fact that mutations in the gene coding for ALK1 (ACVRL1) give rise to a second form of HHT (HHT2) [5], [6]. The gene discussed is ACVRL1; the disease is hereditary hemorrhagic telangiectasia.